Skip to main content
Journal cover image

ACO leakage among gynecologic cancer patients: Incidence, predictors, and impact on annual Medicare expenditure.

Publication ,  Journal Article
Osazuwa-Peters, OL; Greiner, MA; Kaufman, BG; Zambrano Guevara, LM; Dinan, M; Havrilesky, L; Moss, HA
Published in: Gynecol Oncol
August 2024

OBJECTIVE: To examine patterns of Accountable Care Organizations (ACO) leakage, the receipt of healthcare by ACO-assigned patients from institutions outside assigned ACO network, among patients with gynecologic cancer. ACO leakage was estimated as rates of patients seeking care external to their ACO assignment. Factors associated with ACO leakage were identified and cost differences within the first year of cancer diagnosis described. METHODS: Medicare 5% data (2013-2017) was used to quantify rates of leakage among gynecologic cancer patients with stable ACO assignment. Crude and multivariable adjusted risk ratios of ACO leakage risk factors were estimated using log-binomial regression models. Overall and cancer-specific spending differences by ACO leakage status were compared using Wilcoxon rank-sum test. RESULTS: Overall incidence of ACO leakage was 28.1% with highest leakage for outpatient care and uterine cancer patients. ACO leakage risk was 56% higher among Black relative to White patients, and 77% more for those in higher relative to lowest quintiles of median household income. Leakage decreased by 3% and 8% with each unit increase in ACO size and number of subspecialists, respectively. Healthcare costs were 19.5% higher for leakage patients. CONCLUSIONS: ACO leakage rates among gynecologic cancer patients was overall modest, with some regional and temporal variation, higher leakage for certain subgroups and substantially higher Medicare spending in inpatient and outpatient settings for patients with ACO leakage. These findings identify targets for further investigations and strategies to encourage oncologists to participate in ACOs and prevent increased health care costs associated with use of non-ACO providers.

Duke Scholars

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

August 2024

Volume

187

Start / End Page

184 / 191

Location

United States

Related Subject Headings

  • United States
  • Oncology & Carcinogenesis
  • Middle Aged
  • Medicare
  • Incidence
  • Humans
  • Health Expenditures
  • Genital Neoplasms, Female
  • Female
  • Aged, 80 and over
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Osazuwa-Peters, O. L., Greiner, M. A., Kaufman, B. G., Zambrano Guevara, L. M., Dinan, M., Havrilesky, L., & Moss, H. A. (2024). ACO leakage among gynecologic cancer patients: Incidence, predictors, and impact on annual Medicare expenditure. Gynecol Oncol, 187, 184–191. https://doi.org/10.1016/j.ygyno.2024.05.020
Osazuwa-Peters, Oyomoare L., Melissa A. Greiner, Brystana G. Kaufman, Linda M. Zambrano Guevara, Michaela Dinan, Laura Havrilesky, and Haley A. Moss. “ACO leakage among gynecologic cancer patients: Incidence, predictors, and impact on annual Medicare expenditure.Gynecol Oncol 187 (August 2024): 184–91. https://doi.org/10.1016/j.ygyno.2024.05.020.
Osazuwa-Peters OL, Greiner MA, Kaufman BG, Zambrano Guevara LM, Dinan M, Havrilesky L, et al. ACO leakage among gynecologic cancer patients: Incidence, predictors, and impact on annual Medicare expenditure. Gynecol Oncol. 2024 Aug;187:184–91.
Osazuwa-Peters, Oyomoare L., et al. “ACO leakage among gynecologic cancer patients: Incidence, predictors, and impact on annual Medicare expenditure.Gynecol Oncol, vol. 187, Aug. 2024, pp. 184–91. Pubmed, doi:10.1016/j.ygyno.2024.05.020.
Osazuwa-Peters OL, Greiner MA, Kaufman BG, Zambrano Guevara LM, Dinan M, Havrilesky L, Moss HA. ACO leakage among gynecologic cancer patients: Incidence, predictors, and impact on annual Medicare expenditure. Gynecol Oncol. 2024 Aug;187:184–191.
Journal cover image

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

August 2024

Volume

187

Start / End Page

184 / 191

Location

United States

Related Subject Headings

  • United States
  • Oncology & Carcinogenesis
  • Middle Aged
  • Medicare
  • Incidence
  • Humans
  • Health Expenditures
  • Genital Neoplasms, Female
  • Female
  • Aged, 80 and over